Keyphrases
Advanced Ovarian Cancer
15%
Advanced Stage
28%
Age Distribution
10%
Cancer Registration
12%
Cancer Registry
12%
Cervical Cancer
100%
Cervical Cancer Elimination
15%
Cervical Cancer Patients
26%
Cervical Cancer Screening
37%
Chemotherapy
16%
Developing Countries
11%
Diagnostic Modalities
10%
Epithelial Ovarian Cancer
11%
Genotype
11%
Gynecological Cancer
24%
High-risk Human Papillomavirus (HR-HPV)
28%
Histopathological Examination
9%
HPV DNA
11%
HPV16
21%
Human Papillomavirus Genotypes
17%
Human Papillomavirus Vaccine
16%
Hysterectomy
9%
Immune Checkpoint Inhibitors
15%
Indonesia
72%
Indonesian
29%
Indonesian Population
9%
Jakarta
43%
Knowledge Attitude
15%
Knowledge Practices
15%
Meta-analysis of Randomized Controlled Trials
15%
Natural History
9%
Neoadjuvant Chemotherapy
10%
Normal Cervix
9%
Odds Ratio
11%
Pap Smear
10%
Papillomavirus Infections
24%
Patient-reported Outcomes
15%
Precancerous Lesions
9%
Risk Factors
20%
Safety Self-efficacy
15%
Screening Method
12%
Society of Gynecologic Oncology
11%
Sustainable Development Goals
15%
Systematic Meta-analysis
15%
Tumor Necrosis Factor-α
15%
Urban Community
15%
Visual Inspection with Acetic Acid
58%
Wide Local Excision
9%
Women of Reproductive Age
9%
Yolk Sac Tumor
10%
Medicine and Dentistry
4 Iodo 2,5 Dimethoxyamphetamine
7%
Acetic Acid
56%
Age Distribution
9%
Cancer
28%
Cancer Registry
19%
Cervical Cancer
87%
Cervical Cancer Prevention
9%
Cervical Cancer Screening
36%
Cervix
14%
Community Health
7%
Cross Sectional Study
23%
Cryotherapy
9%
Diseases
19%
Endodermal Sinus Tumor
15%
Epitope
7%
Fallopian Tube Cancer
7%
Female Genital Tract Cancer
23%
Gestational Age
11%
Gynecological Oncology
14%
Gynecology
7%
Health Care Cost
8%
Histopathology
21%
Human Papillomavirus Type 16
9%
Hysterectomy
14%
Immune Checkpoint Inhibitor
15%
Insulin Resistance
7%
Krukenberg Tumor
25%
Malignant Neoplasm
18%
Melanoma
7%
Meta-Analysis
15%
Metastatic Carcinoma
9%
Neoadjuvant Chemotherapy
9%
Neoplasm
12%
Ovarian Cancer
16%
Ovarian Tumor
15%
Papanicolaou Stain
13%
Papillomavirus Infection
11%
Patient-Reported Outcome
15%
Precancerous Condition
10%
Prevalence
19%
Radiation Therapy
9%
Randomized Controlled Trial
15%
Retrospective Study
13%
Squamous Cell Carcinoma
12%
Systematic Review
18%
Tobacco Use
7%
Uterine Cervix
7%
Uterine Perforation
9%
Uterine Tube Carcinoma
7%
Wart Virus
26%